The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Novo Nordisk A/S

NYSE: NVO
Last

(U.S.) $46.89

Today's change+0.04 +0.09%
Updated August 26 4:02 PM EDT. Delayed by at least 15 minutes.
 

Novo Nordisk A/S

NYSE: NVO
Last

(U.S.) $46.89

Today's change+0.04 +0.09%
Updated August 26 4:02 PM EDT. Delayed by at least 15 minutes.

Novo Nordisk A/S up slightly

Novo Nordisk A/S closed up just (U.S.)$0.04 Friday to (U.S.)$46.89. Over the last five days, shares have lost 0.02% and sit 2.38% above their 52-week low. This security has underperformed the S&P 500 by 27.09% during the last year.

Key company metrics

  • Open(U.S.) $46.88
  • Previous close(U.S.) $46.85
  • High(U.S.) $47.18
  • Low(U.S.) $46.62
  • Bid / Ask-- / --
  • YTD % change-19.27%
  • Volume1,600,893
  • Average volume (10-day)3,504,862
  • Average volume (1-month)2,747,042
  • Average volume (3-month)1,832,552
  • 52-week range(U.S.) $45.80 to (U.S.) $59.00
  • Beta0.73
  • Trailing P/E22.07×
  • P/E 1 year forward20.75×
  • Forward PEG1.96×
  • Indicated annual dividend(U.S.) $0.45
  • Dividend yield0.97%
  • Trailing EPS(U.S.) $2.12
Updated August 26 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+32.68%

Based on its net profit margin of 32.68%, Novo Nordisk A/S is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.06%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue27,45927,21228,87626,792
Total other revenue--------
Total revenue27,45927,21228,87626,792
Gross profit23,41422,97824,26822,945
Total cost of revenue4,0454,2344,6083,847
Total operating expense14,96214,90317,75114,812
Selling / general / administrative7,7407,6499,2037,903
Research & development3,3313,3044,0343,289
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total-154-284-94-227
Operating income12,49712,30911,12511,980
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax12,60211,95310,31410,136
Income after tax9,9689,4558,2588,383
Income tax, total2,6342,4982,0561,753
Net income9,9689,4558,2588,383
Total adjustments to net income--------
Net income before extra. items9,9689,4558,2588,383
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9,9689,4558,2588,383
Inc. avail. to common incl. extra. items9,9689,4558,2588,383
Diluted net income9,9689,4558,2588,384
Dilution adjustment00--1
Diluted weighted average shares2,5412,5502,5512,572
Diluted EPS excluding extraordinary itemsvalue per share3.923.713.243.26
Dividends per sharevalue per share0.000.006.400.00
Diluted normalized EPSvalue per share3.923.713.243.26